openPR Logo
Press release

Nuclear Medicine/Radiopharmaceuticals Market, New Research, Global Forecast 2022

11-27-2017 12:49 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Research Beam Market

Nuclear Medicine/Radiopharmaceuticals Market, New Research,

Radiopharmaceuticals are pharmaceutical formulations comprising radioactive isotopes that are used in diagnosis and therapeutics. They are simple and small substances that contain a radioactive substance that is used in the treatment of cancer and cardiac & neurological disorders. The conventional chemotherapy methods are being replaced by more convenient therapeutic radiopharmaceuticals for oncology and cancer treatment, which opens up new avenues in the radiopharmaceuticals market. Moreover, it not only helps physicians during diagnosis, but also works as a convenient and safer alternative for patients as compared to X-Rays and other external radiation imaging devices. Radiopharmaceuticals, also known as nuclear medicines, are used in applications such as lymphoma and bone metastasis. F-18, Tc-99, Ga-67, and I-123 are some of the nuclear medicines used in diagnostic procedures, while I-131, Ir-192, Y-90, I-125, Lu-177, and Ra-223 are used in therapeutics procedures.

For More Info, Get Sample : http://bit.ly/2nbMBdg

The world radiopharmaceuticals market is expected to generate a revenue of $8,207.5 million by 2022, the market is currently in its growth stage driven by increasing number of cancer cases and rising awareness about nuclear medicine. Convenience of the treatment with minimally invasive techniques attracts more patients towards radiopharmaceuticals mode of treatment as compared to chemotherapy. The factors that drive the Radiopharmaceuticals Industry include increasing incidence of cardiac patients and adoption of clear imaging technique, with the help of diagnostic equipment such as PET and SPECT. The factors that restrain the growth of the market include supply shortages, logistical difficulties, and limited number of trained medical personnel.

The report segments the radiopharmaceuticals industry on the basis of type, modality, application, end user, and geography. On the basis of type, the market is segmented into diagnostic, therapeutic, and research. Based on modality, the nuclear medicine market is segregated into SPECT, PET, alpha emitters, beta emitters, and brachytherapy. According to application, the market is classified into oncology, cardiology, neurology, thyroid, and others. The geographic breakdown and deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and LAMEA. Asia-Pacific is the highest revenue generating region accounting for about 35.1% of the total market and is projected to grow at a high CAGR of 8.4% during the forecast period.

Comprehensive competitive analysis and profiles of major market players such as Mallinckrodt plc., General Electric Co. (healthcare division), Medtronic, Inc., Bayer AG, Cardinal Health, Inc., Lantheus Medical Imaging, Inc., and IBA Group is also provided in this report.

Enquire About Report : http://bit.ly/2jr9Fj5

KEY BENEFITS FOR STAKEHOLDERS:

• This report provides an extensive analysis of the current and emerging market trends and dynamics in the world nuclear medicine market.
• This report includes a detailed quantitative analysis of the current market and estimations from 2014 to 2022, which contribute in identifying the key market opportunities for growth.
• Exhaustive analysis of the world radiopharmaceuticals market by type helps in understanding the types of radiopharmaceuticals that are currently being used along with the variants that would gain prominence in the future.
• Competitive intelligence (of leading manufacturers of radiopharmaceuticals) helps in understanding the competitive scenario across the geographies.
• Key market players within the radiopharmaceuticals market are profiled in this report and their strategies are analyzed thoroughly. This helps in understanding the competitive outlook of the global nuclear medicine market.

NEUCLEAR MEDICINE/ RADIOPAHRMACEUTICALS MARKET KEY SEGMENTS:

By Type
• Diagnostic
• Therapeutic
• By Modality
• SPECT
• PET
• Alpha-emitters
• Beta-emitters
• Brachytherapy

Also Request For Discount : http://bit.ly/2ABa6SC

By Application
• Oncology
• Cardiology
• Neurology
• Thyroid
• Others

By Procedures
• Oncology
• Cardiovascular
• Central Nervous System
• Endocrine
• Skeletal
• Gastrointestinal
• Genito-urinary
• Pulmonary
• PET & PET-CT
• Therapeutic
• Others

By End-user
• Hospitals and diagnostic centers
• Research institutes

By Geography
• North America
• U.S.
• Canada
• Mexico
• Europe
• Belarus
• Czech Republic
• Greece
• Hungary
• Rest of Europe
• Asia-Pacific
• China
• India
• Korea
• Pakistan
• Rest of Asia-Pacific
• LAMEA
• Brazil
• Argentina
• South Africa
• Rest of LAMEA

Table Of Content

• CHAPTER 1 INTRODUCTION
• CHAPTER 2 EXECUTIVE SUMMARY.
• CHAPTER 3 MARKET OVERVIEW
• CHAPTER 4 WORLD RADIOPHARMACEUTICALS MARKET, BY TYPE, 2014-2022
• CHAPTER 5 WORLD RADIOPHARMACEUTICALS MARKET, BY MODALITY, 2014-2022
• CHAPTER 6 WORLD RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2014-2022
• CHAPTER 7 WORLD RADIOPHARMACEUTICALS MARKET, BY END-USER, 2014-2022
• CHAPTER 8 WORLD RADIOPHARMACEUTICALS MARKET, BY GEOGRAPHY, 2014-2022
• CHAPTER 9 COMPANY PROFILES

About Us
We have a large database of quality and precise market research reports that will be very beneficial for your organization. Reports that we sell our authentic in nature and from reputed publishers, hence it can definitely help you with your growth opportunities. Research Beam will always make sure to bring most ethical and high quality reports. We value your relationship with us and look forward for a long term relation.

Contact Us
Global Head Quarters
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
+1 (800) 910-6452
help@researchbeam.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Nuclear Medicine/Radiopharmaceuticals Market, New Research, Global Forecast 2022 here

News-ID: 833649 • Views:

More Releases from Research Beam Market

Blood Plasma Derivatives Market Growing With $44,333 Million At A CAGR of 9.3% From 2017 To 2023.
Blood Plasma Derivatives Market Growing With $44,333 Million At A CAGR of 9.3% F …
Blood plasma is liquid component of blood where the blood cells are suspended. It contains dissolved proteins (albumins, globulins, and fibrinogen), clotting factors, hormones, and electrolytes. Plasma maintains the blood pressure and helps in exchange of important minerals such as sodium and potassium to maintain the pH balance in the body. Plasma derivatives are products that are manufactured from human plasma by plasma fractionation techniques. These derivatives include albumin, factor
Holter ECG Monitoring Market Growing $418.3 Million By 2023
Holter ECG Monitoring Market Growing $418.3 Million By 2023
Holter monitors are devices that allow prolonged monitoring of heart rhythm from a few days to several months, enabling the detection of infrequent arrhythmias in patients. In addition, holter monitors help identify ventricular tachycardia (VT) in patients with recognized risk of sudden cardiac death. Portability of holter monitors significantly propel the market growth as they can be easily worn by the patients to record heart activity for a certain period
Intermittent Catheters Market Reach $2,950.7 Million By 2023
Intermittent Catheters Market Reach $2,950.7 Million By 2023
The global intermittent catheters market was valued at $1,655.5 million in 2016, and is expected to reach $2,950.7 million by 2023 with a CAGR of 8.7% during the forecast period. Intermittent catheter is a disposable medical device, which is used to drain the urinary bladder when an individual is unable to do it naturally. Intermittent catheter consists of a drainage bag that assists to capture the urine. These catheters are
Continuous Glucose Monitoring Systems Market Registering A CAGR Of 22.9% By 2024
Continuous Glucose Monitoring Systems Market Registering A CAGR Of 22.9% By 2024
Continuous glucose monitoring (CGM) is one of the latest technological advancements in the field of diabetes management. CGM system is a type of glucose monitoring device that functions by inserting a biosensor through transcutaneous or subcutaneous route. The embedded sensor measures the glucose levels in interstitial fluid or blood, and transmits the information using a transmitter to a receiver/monitor for displaying the results. These systems play an integral role in

All 5 Releases


More Releases for CHAPTER

SISA’s Dharshan Shanthamurthy Addresses ISACA Bangalore Chapter
Bengaluru May 1, 2019: SISA Information Security, a global payment security specialist, announced that Mr. Dharshan Shanthamurthy, Founder and CEO, SISA Information Security recently delivered an informative address on payment security to the ISACA Bangalore Chapter on Saturday 27th April 2019. Mr. Shanthamurthy drew from his own first hand observations of the payment industry, garnered over the years. He spoke about emerging trends in the payments industry, including some of
Chapter 4 of 'Meri Pyaari Bindu'
While the first three chapters of Ayushmann Khurrana and Parineeti Chopra starrer 'Meri Pyari Bindu' tickled our funny bones, the fourth chapter has already made its way. Parineeti shared it on her Twitter handle by tweeting, "So easy to scandalise Abhi's MOM!!! Hahhahahaha here is Chapter 4 :) Bindu v/s Ma 😎😎😎 #MeriPyaariBindu." The chapter 4 shows Tom and Jerry equation between Bindu and Abhimanyu's mom. Bindu, who is Abhi's neighbour
AFEA Welcomes New Chapter President
Leader in Financial Literacy Continues to Expand The American Financial Education Alliance is dedicated to providing financial education and increasing financial literacy within communities all over the country. Today, the Board of Directors has chosen to continue to do just that, by unanimously voting in Robert Wolf as the new Chapter President of AFEA’s Orange, CA Chapter. With the addition of Robert Wolf as the new Chapter President, AFEA is expanding
AFEA Welcomes New Chapter President
The American Financial Education Alliance is dedicated to providing financial education and increasing financial literacy within communities all over the country. Today, the Board of Directors has chosen to continue to do just that, by unanimously voting in Anthony Cucchi as the new Chapter President of AFEA’s Newton Square, PA Chapter. With the addition of Anthony Cucchi as the new Chapter President, AFEA is expanding its geographical footprint to cover
AFEA Welcomes New Chapter President
Leader in Financial Literacy Continues to Expand The American Financial Education Alliance is dedicated to providing financial education and increasing financial literacy within communities all over the country. Today, the Board of Directors has chosen to continue to do just that, by unanimously voting in Angelica Jones as the new Chapter President of AFEA’s Glendale, California Chapter. With the addition of Angelica Jones as the new Chapter President, AFEA is expanding
SPS/GZ to Present at the Chapter Meeting of the Chicago Chapter of the NASPP
Chicago, IL, October 20, 2010 -- Stock Plan Solutions/Green Zapato LLC (SPS/GZ), a leader in equity compensation administration and outsourcing today announced that Rick Zatz, CEP, will be presenting at the meeting of the Chicago Chapter of the NASPP in October 27, 2010. The U.S. Treasury Department issued the final regulations relating to the return information statement requirements under IRC 6039. These regulations impose return and information statement reporting requirements on